These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30548342)

  • 1. Influence of canine donor plasma hemostatic protein concentration on quality of cryoprecipitate.
    Drinkhouse M; Brooks MB; Stefanovski D; Marryott K; Callan MB
    J Vet Intern Med; 2019 Jan; 33(1):124-131. PubMed ID: 30548342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of albumin, colloid osmotic pressure, von Willebrand factor, and coagulation factors in canine cryopoor plasma, cryoprecipitate, and fresh frozen plasma.
    Culler CA; Iazbik C; Guillaumin J
    J Vet Emerg Crit Care (San Antonio); 2017 Nov; 27(6):638-644. PubMed ID: 29064153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation factor and hemostatic protein content of canine plasma after storage of whole blood at ambient temperature.
    Walton JE; Hale AS; Brooks MB; Boag AK; Barnett W; Dean R
    J Vet Intern Med; 2014; 28(2):571-5. PubMed ID: 24467263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
    Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
    Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in the fibrinogen and von Willebrand factor content of cryoprecipitate. Implications for reducing donor exposure.
    Hoffman M; Jenner P
    Am J Clin Pathol; 1990 May; 93(5):694-7. PubMed ID: 2327369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC.
    Yazer MH; Triulzi DJ; Hassett AC; Kiss JE
    Transfusion; 2010 May; 50(5):1014-8. PubMed ID: 20003046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and qualitative analysis of coagulation factors in cryoprecipitate prepared from fresh-frozen plasma inactivated with amotosalen and ultraviolet A light.
    Cid J; Caballo C; Pino M; Galan AM; Martínez N; Escolar G; Diaz-Ricart M
    Transfusion; 2013 Mar; 53(3):600-5. PubMed ID: 22738354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of fresh-frozen plasma and cryoprecipitate in dogs with von Willebrand's disease or hemophilia A.
    Stokol T; Parry B
    J Vet Intern Med; 1998; 12(2):84-92. PubMed ID: 9560764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic capability of ultrafiltrated fresh frozen plasma compared to cryoprecipitate.
    Ichikawa J; Iba T; Okazaki R; Fukuda T; Kodaka M; Komori M; Levy JH
    Sci Rep; 2023 Dec; 13(1):21579. PubMed ID: 38062086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro.
    Thomas KA; Shea SM; Spinella PC
    Transfusion; 2021 Jun; 61(6):1943-1954. PubMed ID: 33755208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
    Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
    Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma.
    Hornsey VS; Krailadsiri P; MacDonald S; Seghatchian J; Williamson LM; Prowse CV
    Br J Haematol; 2000 Jun; 109(3):665-70. PubMed ID: 10886222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of von Willebrand factor and factor VIII in canine von Willebrand disease and haemophilia A.
    Stokol T; Trepanier L; Parry BW; Finnin BC
    Res Vet Sci; 1997; 63(1):23-7. PubMed ID: 9368952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems.
    Burnouf T; Caron C; Radosevich M; Goubran HA; Goudemand J; El-Ekiaby M
    Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor.
    Colling ME; Friedman KD; Dzik WH
    Clin Appl Thromb Hemost; 2019; 25():1076029619873976. PubMed ID: 31496264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR; Rigsby P; Barrowcliffe TW
    Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease.
    Ching YN; Meyers KM; Brassard JA; Wardrop KJ
    Am J Vet Res; 1994 Jan; 55(1):102-10. PubMed ID: 8141483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing.
    Lokhandwala PM; O'Neal A; Patel EU; Brunker PAR; Gehrie EA; Zheng G; Kickler TS; Ness PM; Tobian AAR
    Transfusion; 2018 May; 58(5):1126-1131. PubMed ID: 29479708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoprecipitate prepared from plasma virally inactivated by the solvent detergent method.
    Keeling DM; Luddington R; Allain JP; Lawrie AS; Williamson LM
    Br J Haematol; 1997 Jan; 96(1):194-7. PubMed ID: 9012709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.